Language selection

Search

Patent 3081398 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 3081398
(54) English Title: PHOTOTHERAPY SPECTACLES ATTACHMENT
(54) French Title: ACCESSOIRE DE LUNETTES DE PHOTOTHERAPIE
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61N 5/06 (2006.01)
  • A61M 21/00 (2006.01)
  • G02C 11/00 (2006.01)
(72) Inventors :
  • TANG, LUCAS WEN (Canada)
  • CHAN, CLIVE (Canada)
  • DHILLON, JAGBIR (Canada)
  • HAQ, SAAD (Canada)
  • LEE, DONGAOO (Canada)
(73) Owners :
  • LUCAS WEN TANG
(71) Applicants :
  • LUCAS WEN TANG (Canada)
(74) Agent:
(74) Associate agent:
(45) Issued:
(22) Filed Date: 2020-05-27
(41) Open to Public Inspection: 2021-11-27
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract


A spectacles attachment that provides phototherapy.


Claims

Note: Claims are shown in the official language in which they were submitted.


PHOTOTHERAPY SPECTACLES ATTACHMENT
CLAIM OF CLAIMS:
WHAT IS CLAIMED IS:
1. Phototherapy spectacles attachment, comprising:
A housing, which houses the components and provides attachment functionality
to
spectacles.
A minimum of 1 light module.
A sensing module
A power module
A charging module
A communications and processing module
A controls module
And a flexible housing module.
2. The phototherapy spectacles according to claim 1, wherein the light source
module
is placed onto the housing or flexible housing.
3. The phototherapy spectacles according to claim 1, wherein the sensing
module is
placed onto the housing or flexible housing.
4. The phototherapy ophthalmic lenses according to claim 1, wherein the power,
charging, communications and processing, controls modules are placed onto the
housing to provide controls and facilitate functionality.
Date Recue/Date Received 2020-05-27

Description

Note: Descriptions are shown in the official language in which they were submitted.


PHOTOTHERAPY SPECTACLES ATTACHMENT
BACKGROUND
1. Phototherapy uses light, including infrared, visible, and UV light to
treat
various conditions. Most commonly, phototherapy is used to treat sleep and
mood related disorders such as seasonal depression and delayed sleep phase
disorder by exposing the eyes to bright light. Another common form of
phototherapy uses light to treat skin conditions, such as jaundice as well as
scar healing.
2. In a related art, a phototherapy lamp may be provided. A user needs to
sit near
the phototherapy lamp and enable light emitted by the phototherapy lamp to
reach the target treatment area. However, due to the disadvantages of heavy
weight of the phototherapy lamp and tedious position movement, the user
cannot move freely during the therapy.
3. In another related art, a wearable phototherapy product may be provided.
A
user can perform some daily activities, such as sweeping a floor and reading a
book, while wearing the wearable phototherapy product to achieve the purpose
of phototherapy. However, current wearable phototherapy products generally
have special or strange product forms, which affect the aesthetics and
convenience of patients when they are worn.
4. In another related art, a wearable phototherapy product may be provided
in the
form a discreet pair of glasses, using optical technology to reflect light
back
into the eyes of the user to achieve subtle looks using special optical
technology and design. Such is the case in the related application,
CN201911235702.7, PHOTOTHERAPY GLASSES AND GLASSES CASE.
However, a user may prefer to have a solution that is compatible with their
existing spectacles frames, or existing spectacle frames on the market.
I
Date Recue/Date Received 2020-05-27

SUMMARY
5. The disclosure relates to the technical field of terminals, and more
particularly,
to phototherapy spectacles attachment.
6. The disclosure provides phototherapy phototherapy spectacles to solve
the
defects in the related art.
7. According to a first aspect of embodiments of the disclosure,
phototherapy
spectacles attachment are provided. The phototherapy spectacles attachment
include:
8. A housing, which houses the electronic components
9. At least one light emitting module
10. A power module
11. A communications module, to communicate with an external device
12. A light sensing module
BRIEF DESCRIPTION OF THE DRAWINGS
13. The accompanying drawings, which are incorporated in and constitute a
part
of this specification, illustrate embodiments consistent with the disclosure
and,
together with the specification, serve to explain the principles of the
disclosure.
14. Fig. 1 is a schematic structural diagram illustrating phototherapy
spectacles
attachment according to some embodiments of the disclosure.
15. Fig. 2 is a schematic phototherapy spectacles attachment on an example
pair
of spectacles.
DETAILED DESCRIPTION
16. Reference will now be made in detail to exemplary embodiments, examples
of
which are illustrated in the accompanying drawings. The following description
refers to the accompanying drawings in which the same reference numeral in
different drawings represents the same or similar elements unless otherwise
specified. The implementations set forth in the following description of
exemplary embodiments do not represent all implementations consistent with
2
Date Recue/Date Received 2020-05-27

the disclosure. Instead, they are merely examples of apparatuses and methods
consistent with aspects related to the disclosure as recited in the appended
claims.
17. The terms used in the disclosure are for the purpose of describing
particular
embodiments only and are not intended to limit the disclosure. "A/an", "the"
and "said" in a singular form in the disclosure and the appended claims are
also intended to include a plural form, unless other meanings are clearly
specified throughout the disclosure. It should also be understood that term
"and/or" used in the disclosure refers to and includes any or all possible
combinations of one or more associated items that are listed.
18. It should be understood that although the terms first, second, third,
etc. may be
used in the disclosure to describe various information, such information
should not be limited to these terms. These terms are only used to distinguish
the same type of information from each other. For example, without departing
from the scope of the disclosure, first information may also be called second
information and, similarly, second information may also be called first
information. For example, term "if' used here may be explained as "while" or
"when" or "responsive to determining", which depends on the context.
19. Fig. 1 is a schematic structural diagram illustrating the phototherapy
spectacles attachment.
20. Further, the phototherapy spectacles attachment include a minimum of
one
light source module 101, to provide therapeutic lighting effects
21. Further, the phototherapy ophthalmic lenses 100 include a sense module
102,
to providing sensing of ambient conditions to optimize the light source module
101.
22. Further, the phototherapy spectacles attachment 100 may include a
controls
module 103, to allow the user to control the device.
23. Further, the phototherapy spectacles attachment 100 may include a power
module, to store energy required for operations.
24. Further, the phototherapy spectacles attachment 100 may include a
communications and processing module 105, to facilitate communications
3
Date Recue/Date Received 2020-05-27

with an external device, and facilitate the controls of the device for
operations.
25. Further, the phototherapy spectacles attachment may include a charging
module 106, to provide charing to the device.
26. Further, the phototherapy spectacles attachment may include a housing
108, to
house the components.
27. Further, the phototherapy spectacles attachment may include a flexible
housing 107, to allow repositioning of the light module for beneficial
effects.
28. Other embodiments of the disclosure will be apparent to those skilled
in the art
from consideration of the specification and practice of the disclosure
disclosed
here. The disclosure is intended to cover any variations, uses, or adaptations
of
the disclosure following the general principles thereof and including common
knowledge or conventional technical means in the art not disclosed in the
disclosure. It is intended that the specification and examples be considered
as
exemplary only, with a true scope and spirit of the disclosure being indicated
by the following claims.
29. It will be appreciated that the disclosure is not limited to the exact
construction
that has been described above and illustrated in the accompanying drawings,
and that various modifications and changes can be made without departing
from the scope thereof. It is intended that the scope of the disclosure is
only
limited by the appended claims.
4
Date Recue/Date Received 2020-05-27

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Application Not Reinstated by Deadline 2022-05-25
Inactive: Dead - No patent agent appointed 2022-05-25
Inactive: Cover page published 2021-11-30
Application Published (Open to Public Inspection) 2021-11-27
Deemed Abandoned - Failure to Respond to a Notice Requiring Appointment of Patent Agent 2021-05-25
Letter Sent 2021-02-24
Inactive: Ack. of Reinst. (Due Care Not Required): Corr. Sent 2021-02-24
Correct Applicant Requirements Determined Compliant 2021-02-24
Inactive: Name change/correct refused-Correspondence sent 2021-01-07
Reinstatement Requirements Deemed Compliant for All Abandonment Reasons 2021-01-07
Inactive: Compliance - Formalities: Resp. Rec'd 2021-01-07
Correct Applicant Request Received 2021-01-07
Inactive: Office letter 2021-01-07
Inactive: Correspondence - Formalities 2020-11-29
Correct Applicant Request Received 2020-11-29
Inactive: Compliance - Formalities: Resp. Rec'd 2020-11-29
Deemed Abandoned - Failure to Respond to Notice of Non Compliance 2020-09-28
Inactive: COVID 19 - Deadline extended 2020-08-19
Inactive: IPC assigned 2020-08-19
Inactive: First IPC assigned 2020-08-18
Inactive: IPC assigned 2020-08-18
Inactive: IPC assigned 2020-08-18
Inactive: Office letter 2020-08-07
Inactive: COVID 19 - Deadline extended 2020-08-06
Inactive: COVID 19 - Deadline extended 2020-07-16
Letter sent 2020-06-30
Filing Requirements Determined Compliant 2020-06-30
Inactive: Compliance - Formalities: Resp. Rec'd 2020-06-27
Letter Sent 2020-06-26
Common Representative Appointed 2020-05-27
Small Entity Declaration Determined Compliant 2020-05-27
Application Received - Regular National 2020-05-27
Inactive: QC images - Scanning 2020-05-27

Abandonment History

Abandonment Date Reason Reinstatement Date
2020-09-28

Fee History

Fee Type Anniversary Year Due Date Paid Date
Application fee - small 2020-05-27 2020-05-27
Reinstatement 2021-09-28 2021-01-07
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
LUCAS WEN TANG
Past Owners on Record
CLIVE CHAN
DONGAOO LEE
JAGBIR DHILLON
SAAD HAQ
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 2020-05-27 4 175
Drawings 2020-05-27 2 72
Claims 2020-05-27 1 24
Abstract 2020-05-27 1 5
Representative drawing 2021-11-30 1 14
Cover Page 2021-11-30 1 36
Courtesy - Filing certificate 2020-06-30 1 575
Courtesy - Abandonment Letter (R65) 2020-11-23 1 545
Courtesy - Acknowledgment of Reinstatement (Request for Examination (Due Care not Required)) 2021-02-24 1 410
Commissioner's Notice - Appointment of Patent Agent Required 2021-02-24 1 440
Courtesy - Abandonment Letter (appointment of patent agent) 2021-07-20 1 550
New application 2020-05-27 5 123
Commissioner’s Notice - Non-Compliant Application 2020-06-26 2 198
Courtesy - Office Letter 2020-08-07 2 188
Courtesy - Request for Correction of Error in Name non-Compliant 2021-01-07 2 194
Courtesy - Office Letter 2021-01-07 2 191
Modification to the applicant/inventor / Compliance correspondence 2021-01-07 6 1,042